Quick Answer
ANI PHARMACEUTICALS INC reported Diluted EPS of $3.32 per share for fiscal year 2025.
ANI PHARMACEUTICALS INC Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | $3.32 | +419.2% |
| 2024 | -$1.04 | -222.4% |
| 2023 | $0.85 | +127.9% |
| 2022 | -$3.05 | +10.3% |
| 2021 | -$3.40 | -80.9% |
| 2020 | -$1.88 | -476.0% |
| 2019 | $0.50 | -61.5% |
| 2018 | $1.30 | +1544.4% |
| 2017 | -$0.09 | -126.5% |
| 2016 | $0.34 | -74.2% |
| 2015 | $1.32 | -49.0% |
| 2014 | $2.59 | +381.5% |
| 2013 | -$0.92 | +27.6% |
| 2012 | -$1.27 | +59.7% |
| 2011 | -$3.15 | +25.2% |
| 2010 | -$4.21 | -200.7% |
| 2009 | -$1.40 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $1.13 | +189.0% | +213.9% |
| June 30, 2025 | $0.36 | +357.1% | -47.8% |
| March 31, 2025 | $0.69 | -15.9% | +154.3% |
| September 30, 2024 | -$1.27 | -382.2% | -807.1% |
| June 30, 2024 | -$0.14 | -148.3% | -117.1% |
| March 31, 2024 | $0.82 | +1266.7% | +82.2% |
| September 30, 2023 | $0.45 | +181.8% | +55.2% |
| June 30, 2023 | $0.29 | +130.9% | +383.3% |
- ANI PHARMACEUTICALS INC showed an increase of +419.2% in Diluted EPS compared to the prior fiscal year.
- Over the 2009–2025 period, ANI PHARMACEUTICALS INC’s diluted eps has grown by 337.1% (from $1.40 per share (loss) to $3.32 per share).
- The most recent figure is from ANI PHARMACEUTICALS INC’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 27, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: